NAMS NewAmsterdam Pharma Company N.V. logo

NAMS NewAmsterdam Pharma Company N.V.

Healthcare
$36.11+1.89%ClosedMarket Cap: $4.22B

As of 2026-05-26

Insider Statistics (Q1 2026)

Acquisitions

34

Dispositions

45

Buy/Sell Ratio

0.76

Net Shares

-534,933

Shares Acquired

2,243,319

Shares Disposed

2,778,252

Total Bought ($)

$0.00

Total Sold ($)

$31.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu Mar 12LANGE LOUIS GdirectorSell44,173$30.4110,806
Thu Mar 12LANGE LOUIS GdirectorSell446$31.2310,360
Tue Mar 10LANGE LOUIS GdirectorSell44,619$11.5054,979
Tue Mar 10LANGE LOUIS GdirectorSell28,186$29.410
Mon Mar 09Kastelein Johannes Jacob Pieterdirector, officer: Chief Scientific OfficerSell104,467$0.00715,762
Mon Mar 09Kastelein Johannes Jacob Pieterdirector, officer: Chief Scientific OfficerSell101,409$0.00520,229
Mon Mar 09Kastelein Johannes Jacob Pieterdirector, officer: Chief Scientific OfficerSell94,124$0.00621,638